Castle Biosciences Newsroom

Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion

Zacks Jul 22 09:05 ET

Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma

BusinesswireJul 22 07:00 ET

Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

BusinesswireJul 15 07:00 ET

These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird

Seeking AlphaJul 12 14:30 ET

All You Need to Know About Castle Biosciences (CSTL) Rating Upgrade to Strong Buy

Yahoo FinanceJul 12 12:00 ET

Castle Biosciences Honored With Top Workplaces Awards

Yahoo FinanceJul 11 07:00 ET

Top 5 Health Care Stocks That May Explode In July

BenzingaJul 8 08:40 ET

Express News | Castle Biosciences Down 16.1% After Cancer Test Fails to Secure Insurance Coverage

ReutersJul 5 13:59 ET

Castle Biosciences Is Maintained at Outperform by Baird

Dow JonesJul 5 13:03 ET

Castle Biosciences Price Target Maintained With a $34.00/Share by Baird

Dow JonesJul 5 13:03 ET

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

BenzingaJul 5 12:59 ET

Castle Biosciences Analyst Ratings

BenzingaJul 5 12:49 ET

Castle Biosciences Slides After Medicare Coverage Update

Seeking AlphaJul 5 12:07 ET

Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $34

Moomoo NewsJul 5 11:31 ET · Ratings

Leerink Partners Maintains Castle Biosciences(CSTL.US) With Buy Rating

Moomoo NewsJul 5 11:31 ET · Ratings

Castle Biosciences: Poised for Growth Amidst Favorable Reimbursement Outcomes and Strong Financial Performance

TipRanksJul 5 11:15 ET

Castle Biosciences(CSTL.US) Officer Sells US$59,278.63 in Common Stock

Moomoo NewsJul 3 16:59 ET

Form 144 | Castle Biosciences(CSTL.US) Officer Proposes to Sell 531.34K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Castle Biosciences(CSTL.US)$ Officer Kristen Oelschager intends to sell 24,407 shares of its common stock on Jul 1, with a total market value of approximately $531.34K.

Moomoo NewsJul 1 16:50 ET

CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsJun 24 07:33 ET · Ratings

Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences' TissueCypher Test

BusinesswireJun 24 07:00 ET